Combined Molecular Testing for Influenza, SARS-CoV-2, and RSV RNA From Different Upper Airway Specimens.

NCT05765838 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2023-03-28

No results posted yet for this study

Summary

This is a comparative prospective diagnostic accuracy study reported according to the STARD guidelines. Citizens at an outpatient COVID19 test facility at Testcenter Danmark Valby will be invited to participate in the study on a volunteer basis. The enrolled participants will have the planned oropharyngeal swab performed in the test center and sent for a SARS-CoV-2 RT-PCR test at TestCenter Danmark, Statens Serum Institut, Copenhagen, Denmark as usual. Besides the planned oropharyngeal swab performed in the test center, the participants will have additional specimens collected in form of saliva, nasopharyngeal-, nasal-, and oropharyngeal swabs. These will all be used for the detection of nucleic acids from the four most common strains of influenza (B Yamagata, B Victoria, A H1N1 and A H3N2), SARS-CoV-2 and RSV A/B. Further we will measure immune mediating cytokines, chemokines, and interleukins in the different specimens. These analyses will be performed at Technical University of Denmark (DTU).

Conditions

Interventions

DIAGNOSTIC_TEST

(NPS right - Nasal swab left - OPS)

Collection of nasopharyngeal-, nasal-, and oropharyngeal swabs in randomized order

DIAGNOSTIC_TEST

(NPS left - Nasal swab right - OPS)

Collection of nasopharyngeal-, nasal-, and oropharyngeal swabs in randomized order

DIAGNOSTIC_TEST

(Nasal swab right - NPS left - OPS)

Collection of nasopharyngeal-, nasal-, and oropharyngeal swabs in randomized order

DIAGNOSTIC_TEST

(Nasal swab left - NPS right - OPS)

Collection of nasopharyngeal-, nasal-, and oropharyngeal swabs in randomized order

DIAGNOSTIC_TEST

(NPS right - OPS - Nasal swab left)

Collection of nasopharyngeal-, nasal-, and oropharyngeal swabs in randomized order

DIAGNOSTIC_TEST

(NPS left - OPS - Nasal swab right)

Collection of nasopharyngeal-, nasal-, and oropharyngeal swabs in randomized order

DIAGNOSTIC_TEST

(Nasal swab right - OPS - NPS left)

Collection of nasopharyngeal-, nasal-, and oropharyngeal swabs in randomized order

DIAGNOSTIC_TEST

(Nasal swab left - OPS - NPS right)

Collection of nasopharyngeal-, nasal-, and oropharyngeal swabs in randomized order

DIAGNOSTIC_TEST

(OPS - NPS right - Nasal swab left)

Collection of nasopharyngeal-, nasal-, and oropharyngeal swabs in randomized order

DIAGNOSTIC_TEST

(OPS - NPS left - Nasal swab right)

Collection of nasopharyngeal-, nasal-, and oropharyngeal swabs in randomized order

DIAGNOSTIC_TEST

(OPS - Nasal swab left - NPS right)

Collection of nasopharyngeal-, nasal-, and oropharyngeal swabs in randomized order

DIAGNOSTIC_TEST

(OPS - Nasal swab right - NPS left)

Collection of nasopharyngeal-, nasal-, and oropharyngeal swabs in randomized order

Sponsors & Collaborators

  • Rigshospitalet, Denmark

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-03
Primary Completion
2023-04-01
Completion
2023-07-01

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05765838 on ClinicalTrials.gov